Director, Clinical Development

Direct message the job poster from 89bio

Company Description

89bio is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for treating liver and cardio-metabolic diseases. The company's lead product candidate, BIO
89-100, is engineered to treat nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). Recent clinical data indicate BIO
89-100's favorable safety profile and significant reductions in liver fat and lipid markers. Headquartered in San Francisco with operations in Herzliya, Israel, 89bio values putting patients first, operating with integrity, collaborating as a team, and maintaining a scientific and rational approach.

Role Description

This is a full-time hybrid role for a Director, Clinical Development. The role is based in San Francisco, CA, with flexibility for some work-from-home arrangements. The Director, Clinical Development will be responsible for clinical trial site engagement for a large Phase 3 program in MASH and will have a primary role in developing relationships with gastroenterologists/hepatologists. Other clinical research responsibility will involve working with a multidisciplinary team to review study data.

The position will involve 50% travel.

Qualifications

• Experience in Clinical Study Design and Clinical Development
• Knowledge of Medical Affairs and Regulatory Submissions
• Strong leadership and team collaboration skills
• Excellent communication and problem-solving abilities
• Advanced degree (MD, PhD, Pharm
  
  D, or RN) in a relevant field is preferred
• Previous experience in biopharmaceutical or related industries is a plus
• Knowledge of Metabolic Disorders a plus

• Director

• Full-time

• Research, Analyst, and Information Technology